​

Co-Diagnostics (CODX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CODX Stock Forecast

Co-Diagnostics (CODX) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $6.00, with a high of $6.00 and a low of $6.00. This represents a 100.00% increase from the last price of $3.00.

- $1 $2 $3 $4 $5 $6 High: $6 Avg: $6 Low: $6 Last Closed Price: $3

CODX Stock Rating

Co-Diagnostics stock's rating consensus is Hold, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 2 Buy (40.00%), 3 Hold (60.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 5 0 3 2 Strong Sell Sell Hold Buy Strong Buy

CODX Price Target Upside V Benchmarks

TypeNameUpside
StockCo-Diagnostics100.00%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks19.94%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$3.00$3.00$3.00
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 261-1--2
Dec, 251-1--2
Nov, 25-11--2
Oct, 25-11--2
Sep, 25-11--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 14, 2022H.C. Wainwright$6.00$3.6564.38%100.00%
Aug 15, 2022H.C. Wainwright$9.00$4.48100.89%200.00%
May 16, 2022H.C. Wainwright$12.00$4.55163.74%300.00%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 26, 2025Maxim GroupHoldupgrade

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$1.27$-0.45$-1.20$-1.24---
Avg Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
High Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
Low Forecast$1.10$0.09$-0.90$-1.22$-1.17$0.10$0.25
Surprise %15.45%-600.00%33.33%1.64%---

Revenue Forecast

$0 $20M $40M $60M $80M $100M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$97.89M$34.22M$6.81M$3.92M---
Avg Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
High Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
Low Forecast$98.42M$38.32M$6.88M$4.14M$1.50M$77.63M$5.92M
Surprise %-0.54%-10.70%-1.02%-5.45%---

Net Income Forecast

$-40M $-24M $-8M $8M $24M $40M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27
Reported$36.66M$-14.24M$-35.33M$-37.64M---
Avg Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
High Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
Low Forecast$32.21M$2.64M$-26.41M$-35.80M$-34.34M$2.93M$7.34M
Surprise %13.82%-639.08%33.78%5.13%---

CODX Forecast FAQ

Is Co-Diagnostics stock a buy?

Co-Diagnostics stock has a consensus rating of Hold, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 2 Buy, 3 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Co-Diagnostics is a neutral investment for most analysts.

What is Co-Diagnostics's price target?

Co-Diagnostics's price target, set by 5 Wall Street analysts, averages $6 over the next 12 months. The price target range spans from $6 at the low end to $6 at the high end, suggesting a potential 100.00% change from the previous closing price of $3.

How does Co-Diagnostics stock forecast compare to its benchmarks?

Co-Diagnostics's stock forecast shows a 100.00% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (19.94%).

What is the breakdown of analyst ratings for Co-Diagnostics over the past three months?

  • January 2026: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2025: 50.00% Strong Buy, 0% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is Co-Diagnostics’s EPS forecast?

Co-Diagnostics's average annual EPS forecast for its fiscal year ending in December 2025 is $-1.17, marking a -5.65% decrease from the reported $-1.24 in 2024. Estimates for the following years are $0.1 in 2026, and $0.25 in 2027.

What is Co-Diagnostics’s revenue forecast?

Co-Diagnostics's average annual revenue forecast for its fiscal year ending in December 2025 is $1.5M, reflecting a -61.69% decrease from the reported $3.92M in 2024. The forecast for 2026 is $77.63M, and $5.92M for 2027.

What is Co-Diagnostics’s net income forecast?

Co-Diagnostics's net income forecast for the fiscal year ending in December 2025 stands at $-34.336M, representing a -8.78% decrease from the reported $-37.639M in 2024. Projections indicate $2.93M in 2026, and $7.34M in 2027.